ADAR1 Capital Management, LLC

AUSTIN, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗Includes amendment (13F-HR/A, 2026-11-16)
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.33B2026 Q3+ $16.7M options (notional, not included)Cash-like 0.6%Weight of Treasury-bill ETFs of a year or less (SGOV, BIL, SHV, USFR, TFLO…) in the book. A 13F shows no cash or money-market funds; this is the closest the filing comes. It is not the fund's actual cash level.
Positions272
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.38.7%

ADAR1 Capital Management, LLC reported 272 positions worth $2.33B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ABVX (8.6%). Biggest move: exit CRNXGBP ($45.7M).

10 / 272 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ABVXAbivax S.A.$203.1M8.65%2,050,822———
▸ 2 SPYSPDR S&P 500$135.5M5.77%177,624——-3.0%
▸ 3 PTGXProtagonist Therapeutics$134.0M5.71%951,403——-11.4%
▸ 4 ROIVRoivant Sciences$112.6M4.79%3,079,526——+5.6%
▸ 5 ZLABZai Lab$89.1M3.79%3,381,364——-10.9%
▸ 6 IMVTImmunovant$71.5M3.04%2,115,502——-1.5%
▸ 7 XENEXenon Pharmaceuticals$43.2M1.84%1,162,029——+5.6%
▸ 8 DNLIDenali Therapeutics$42.8M1.82%2,072,050——-12.5%
▸ 9 BOXXEa Series$39.9M1.70%337,125———
▸ 10 SEPNSepterna$38.1M1.62%974,396——+6.5%

Pro Feature

The remaining 262 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does ADAR1 Capital Management, LLC hold as of Q3 2026?

ADAR1 Capital Management, LLC reported 272 positions worth $2.33B in its Q3 2026 13F filing. Largest positions: ABVX (8.6%), SPY (5.8%), PTGX (5.7%), ROIV (4.8%) and ZLAB (3.8%).

What did ADAR1 Capital Management, LLC buy in Q3 2026?

New positions: ABCL, VOGENX INC, BEAM, VIKING THERAPEUTICS INC and PRAX (43 in all). Added to: XENE, SPY, AURA, ABVX and DNLI (86 in all).

What did ADAR1 Capital Management, LLC sell in Q3 2026?

Reduced: INSP, IMVT, OVID, ABUS and IVA (61 in all). Sold out entirely: CRNXGBP, IWM, SPY, XBI and FTH (48 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.